Abstract
We previously demonstrated that delivery of a gene encoding an anti-erbB-2 intracellular single-chain antibody (sFv) resulted in down-regulation of cell surface erbB-2 levels and induction of apoptosis in erbB-2 overexpressing ovarian cancer cells. Based upon these findings, we hypothesized that human breast carcinomas overexpressing erbB-2 would be similarly affected by this genetic intervention. We evaluated the phenotypic effects resulting from intracellular expression of the anti-erbB-2 sFv on the human breast cancer cell lines MDA-MB-361, SK-BR-3, BT-474, MCF-7 and MDA-MB-231. Recombinant adenoviruses encoding either a reporter gene (AdCMVLacZ) or the endoplasmic reticulum (ER) directed anti-erbB-2 sFv (Ad21) were delivered to various breast cancer cell lines. Cell viability was determined by a proliferation assay and fluorescent microscopy allowed visualization of apoptotic cells. An erbB-2 ELISA quantified the endogenous erbB-2 levels of each cell line. The anti-erbB-2 sFv-encoding-adenovirus, Ad21, but not the beta-galactosidase encoding adenovirus, AdCMVLacZ, was cytotoxic to > 95% of the tumor cells in the MDA-MB-361 and SK-BR-3 lines, and > 60% of the tumor cells in the BT-474 line. In marked contrast, the MCF-7 and ...Continue Reading
Citations
Jan 7, 2000·Journal of Cellular Physiology·S MénardS M Pupa
Jul 6, 2000·BioEssays : News and Reviews in Molecular, Cellular and Developmental Biology·D Yu, M C Hung
Jul 20, 1999·Journal of Immunological Methods·R E Kontermann, R Müller
Feb 18, 1999·Current Opinion in Chemical Biology·D A Jones, F A Fitzpatrick
Jul 16, 2003·Drug Resistance Updates : Reviews and Commentaries in Antimicrobial and Anticancer Chemotherapy·Jin-Shing ChenMien-Chie Hung
Jun 1, 1997·Breast Cancer Research and Treatment·J M RuppertT V Strong
Jan 18, 2006·Cancer Gene Therapy·M A Stoff-KhaliliD T Curiel
Sep 19, 1998·Human Gene Therapy·H G ZhangJ D Mountz
Oct 30, 1998·Human Gene Therapy·M PelegrinM Piechaczyk
Feb 15, 2013·Journal of Virology·Wondimagegnehu M TeferiDavid H Evans
Jul 1, 2005·Breast Cancer Research : BCR·Marion LanteriJean-Claude Lefebvre
Oct 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·E Tse, T H Rabbitts
Dec 1, 1998·Stem Cells·J S Ross, J A Fletcher
Mar 21, 2007·Journal of Cellular and Molecular Medicine·Thomas Böldicke
Aug 8, 2015·MAbs·Andrea L J MarschallThomas Böldicke
Jun 16, 2004·Journal of Controlled Release : Official Journal of the Controlled Release Society·Shih-Jiuan ChiuRobert J Lee
Apr 15, 1999·Seminars in Cancer Biology·J S Ross, J A Fletcher
Apr 16, 2002·British Journal of Cancer·G C HuangR J Epstein
Jun 13, 2000·Oncogene·D JeanM Bar-Eli
May 31, 2007·American Journal of Physiology. Endocrinology and Metabolism·Subbiah PugazhenthiJawed Alam
Jan 13, 2001·Oncogene·D Yu, M C Hung
Dec 31, 1997·The Journal of Biological Chemistry·F J HoedemaekerD R Rose
Mar 9, 2004·The Journal of Biological Chemistry·Jing ZhaoAn-Gang Yang
Jun 24, 1999·Molecular Endocrinology·G LazennecB S Katzenellenbogen
Mar 16, 2001·Breast Cancer Research : BCR·D T Curiel
Mar 16, 2001·Breast Cancer Research : BCR·J Gómez-NavarroJ Xiang
Oct 16, 1999·International Journal of Cancer. Journal International Du Cancer·N UedoA Nakaizumi
Jun 3, 2006·Cancer Research·Chun-Chiang WenWon-Bo Wang